Everest Medicines announced that the Company expects to record a total revenue ranging between RMB124 million and RMB126 million for 2023, according to preliminary review of unaudited management accounts.
Everest Medicines announced that the Company expects to record a total revenue ranging between RMB124 million and RMB126 million for 2023, according to preliminary review of unaudited management accounts.